Latest Nodular Acne News
Aesthera Corporation, the global leader in technologically advanced Photopneumatic (PPx) aesthetic technology announced today that world renowned dermatologist, Dr. Frederic Brandt, is now offering Isolaz , the breakthrough painless laser therapy for the treatment of acne.
The leading Indian drug maker, Ranbaxy has acquired the rights from Bristol-Myers Squibb (BMS) to manufacture and market 13 dermatology brands in the United States for $25 million. This is Ranbaxy?s first major brand acquisition in the US.
Ranbaxy Laboratories has acquired the US rights to a group of 13 dermatology products from Bristol-Myers Squibb.
You survived high school. You chucked chocolate. You scrub your face religiously. Yet the acne won't go away. Unfortunately, bad skin isn't just for teens.
Ranbaxy Laboratories Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , announced today that it has acquired from Bristol-Myers Squibb Company the U.S. rights to a group of 13 dermatology products.
Mumbai, May 28 : Ranbaxy Laboratories has acquired the US brand rights to 13 dermatology products from Bristol-Myers Squibb Company for an estimated consideration of $26 million. The acquisition was made by wholly owned subsidiary Ranbaxy Laboratories Inc.
Ranbaxy earned $114 million from its US operations in 2006. It launched 10 new products during the year. The company said that the revenues from the sale of the newly acquired brands would be reflected from the next quarter.
|
